Dan Hartley
General Counsel chez GENUS PLC
Fortune : 963 604 $ au 31/03/2024
Profil
Dan Hartley is currently working as the Secretary & Group General Counsel at Genus Plc since 2014.
Prior to this, he worked as the Senior Vice President & International Counsel at Shire Plc.
Mr. Hartley completed his undergraduate degree from The University of Sydney and his graduate degree from the University of Wollongong.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENUS PLC
0,07% | 14/09/2023 | 43 218 ( 0,07% ) | 963 604 $ | 31/03/2024 |
Postes actifs de Dan Hartley
| Sociétés | Poste | Début |
|---|---|---|
| GENUS PLC | General Counsel | 09/06/2014 |
Anciens postes connus de Dan Hartley
| Sociétés | Poste | Fin |
|---|---|---|
| SHIRE | General Counsel | - |
Formation de Dan Hartley
| The University of Sydney | Undergraduate Degree |
| University of Wollongong | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENUS PLC | Process Industries |
| Entreprise privées | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
